Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single Arm, Open Label Post Market Study Assessing the Safety and Efficacy of Nerivio for the Treatment of Migraine in Children Under the Age of 12

NCT06138756 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT06138756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06138756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single Arm, Open Label Post Market Study Assessing the Safety and Efficacy of Nerivio for the Treatment of Migraine in Children Under the Age of 12
Lead sponsor
Theranica
Phase
Observational
Overall status
Completed
Start date
October 1, 2023
Completion date
June 1, 2024
Enrollment
293 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine